Evidence map›Paper›PMID 33288385›Full record

ArticleTrends in microbiology2021

Joining European Scientific Forces to Face Pandemics.

M Helena Vasconcelos, Stefano Alcaro, Virginia Arechavala-Gomeza, Jan Baumbach, Fernanda Borges, Tiziana A L Brevini, Javier De Las Rivas, Yvan Devaux, Pavel Hozak, Minna M Keinänen-Toivola and 12 more

Abstract read
In one paragraph

Article in Trends in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Current Advances in 3D Tissue and Organ Reconstruction.International journal of molecular sciences · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

M Helena Vasconcelosi3S, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, PT-4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP, Institute of Molecular Pathology and Immunology, University of Porto, PT-4200-135 Porto, Portugal; Department of Biological Sciences, FFUP-Faculty of Pharmacy, University of Porto, PT-4050-313 Porto, Portugal.
Stefano AlcaroDipartimento di Scienze della Salute, Università Magna Græcia di Catanzaro, Viale Europa, IT-88100, Catanzaro, Italy; Net4Science srl, Università Magna Græcia di Catanzaro, Viale Europa, IT-88100, Catanzaro, Italy.
Virginia Arechavala-GomezaNeuromuscular Disorders, Biocruces Bizkaia Health Research Institute, ES-48903, Barakaldo, Spain; Ikerbasque, Basque Foundation for Science, ES-48009, Bilbao, Spain.
Jan BaumbachExperimental Bioinformatics, School of Life Sciences Weihenstephan, Technical University of Munich, DE-85354, Munich, Germany.
Fernanda BorgesCIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, PT-4169-007, Porto, Portugal.
Tiziana A L BreviniLaboratory of Biomedical Embryology, Center for Stem Cell Research UniSTEM, University of Milan, IT-20133 Milan, Italy.
Javier De Las RivasBioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IMBCC, CSIC/USAL/IBSAL), Consejo Superior de Investigaciones Científicas and University of Salamanca, Campus Miguel de Unamuno, ES-37007 Salamanca, Spain.
Yvan DevauxCardiovascular Research Unit, Department of Population Health, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.
Pavel HozakDepartment of Biology of the Cell Nucleus, Institute of Molecular Genetics, Czech Academy of Sciences, CZ-14220, Prague, Czech Republic.
Minna M Keinänen-ToivolaSatakunta University of Applied Sciences, Faculty of Technology, FI-26100 Rauma, Finland.
Giovanna LattanziCNR, National Research Council of Italy, Institute of Molecular Genetics Unit of Bologna, IT-40136, Bologna, Italy; IRCCS Istituto Ortopedico Rizzoli, IT-40136, Bologna, Italy.
Thomas MohrScienceConsult, DI Thomas Mohr KG, AT-2353, Guntramsdorf, Austria; Department of Medicine I, Division: Institute of Cancer Research, Comprehensive Cancer Center Vienna, Medical University of Vienna, AT-1090 Vienna, Austria.
Modra MurovskaRīga Stradiņš University, Institute of Microbiology and Virology, LV-1007, Riga, Latvia.
Bhupesh K PrustyJulius-Maximilians-Universität, Institute for Virology and Immunobiology, DE-97078, Würzburg, Germany.
Roy A QuinlanDepartment of Biosciences, University of Durham, Upper Mountjoy Science Site, Durham DH1 3LE, UK.
Dolores Pérez-SalaDepartment of Structural and Chemical Biology, Centro de Investigaciones Biológicas Margarita Salas, CSIC, ES-28040 Madrid, Spain.
Carmen ScheibenbogenInstitut für Med. Immunologie, Charité Campus Virchow Klinikum, DE-13353, Berlin, Germany.
Harald H H W SchmidtDepartment of Pharmacology and Personalised Medicine, MeHNS, FHML, Maastricht University, NL-6200 Maastricht, The Netherlands.
Isabel SilveiraGenetics of Cognitive Dysfunction Laboratory, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, PT-4200-135 Porto, Portugal; IBMC, Institute for Molecular and Cell Biology, Universidade do Porto, PT-4200-135 Porto, Portugal.
Paolo TieriCNR Consiglio Nazionale delle Ricerche, IAC Istituto per le Applicazioni del Calcolo, IT-00185, Rome, Italy.
Alexander ToliosDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, AT-1090, Vienna, Austria; Center for Physiology and Pharmacology, Medical University of Vienna, AT-1090, Vienna, Austria; Center for Medical Statistics, Informatics, and Intelligent Systems, Institute for Artificial Intelligence and Decision Support, Medical University of Vienna, AT-1090, Vienna, Austria.
Chiara RigantiDepartment of Oncology, University of Turin, IT-10126, Turin, Italy. Electronic address: chiara.riganti@unito.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the international guidelines on the containment of the coronavirus disease 2019 (COVID-19) pandemic, the European scientific community was not sufficiently prepared to coordinate scientific efforts. To improve preparedness for future pandemics, we have initiated a network of nine European-funded Cooperation in Science and Technology (COST) Actions that can help facilitate inter-, multi-, and trans-disciplinary communication and collaboration.

Indexed as

Biomedical ResearchCommunicationCOVID-19EuropeHumansLaboratory PersonnelPandemicsSARS-CoV-2COST ActionsCOVID-19interdisciplinary networkpandemic

Identifiers

PMID33288385
PMCPMC7716745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.